Antitumor activity of NLG207 (Formerly CRLX101) in combination with enzalutamide in preclinical prostate cancer models

Keith T. Schmidt, Cindy H. Chau, Jonathan D. Strope, Alwin D.R. Huitema, Tristan M. Sissung, Douglas K. Price, William D. Figg^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review